Trump Nominates Erica Schwartz as CDC Director Amid Vaccine Policy Controversies

U.S. President Donald Trump nominates Erica Schwartz, who served during the COVID-19 pandemic, as CDC director amidst leadership changes. The nomination is seen as a traditional choice, diverging from Robert F. Kennedy Jr.'s contentious vaccine stance, in preparation for the upcoming midterm elections.

President Donald Trump has announced his intention to nominate Erica Schwartz, the former deputy surgeon general during the COVID-19 pandemic, as the new director of the Centers for Disease Control and Prevention (CDC). This decision follows significant leadership shifts at the health agency.

The nomination is viewed as a strategic move by the White House to focus on less contentious health issues, contrasting with Health Secretary Robert F. Kennedy Jr.'s divisive vaccine policies. At recent congressional hearings, Kennedy skirted questions related to vaccines, as Republicans gear up for challenging midterm elections.

This change comes after a legal setback to Kennedy's vaccine policy reform. Critics like Aaron Siri, a close ally of Kennedy, argue that Schwartz's strong stance on vaccine mandates makes her unsuitable for the role. If confirmed, Schwartz will report to Kennedy, who remains a controversial figure in the vaccine debate.

(With inputs from agencies.)